tiprankstipranks
Lemaitre Vascular (DE:LHU)
NASDAQ:LHU
Germany Market
LHU
Lemaitre Vascular
RESEARCH TOOLSreports

Lemaitre Vascular (LHU) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

LHU Analyst Ratings

Moderate Buy
7Ratings
Moderate Buy
5 Buy
2 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Lemaitre
Vascular
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

LHU Stock 12 Month Forecast

Average Price Target

€105.92
▲(12.08% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Lemaitre Vascular in the last 3 months. The average price target is €105.92 with a high forecast of €116.25 and a low forecast of €89.56. The average price target represents a 12.08% change from the last price of €94.50.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"68":"€68","117":"€117","80.25":"€80.3","92.5":"€92.5","104.75":"€104.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":116.24983245000001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€116.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":105.91651401,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€105.92</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":89.55542648000001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€89.56</span>\n  </div></div>","useHTML":true}}],"tickPositions":[68,80.25,92.5,104.75,117],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81,83.71152557307693,86.42305114615385,89.13457671923078,91.84610229230769,94.55762786538462,97.26915343846154,99.98067901153847,102.6922045846154,105.40373015769231,108.11525573076923,110.82678130384616,113.53830687692309,{"y":116.24983245000001,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81,82.91665492384615,84.8333098476923,86.74996477153846,88.66661969538461,90.58327461923076,92.49992954307692,94.41658446692307,96.33323939076924,98.24989431461539,100.16654923846154,102.0832041623077,103.99985908615385,{"y":105.91651401,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81,81.65810972923077,82.31621945846155,82.9743291876923,83.63243891692308,84.29054864615385,84.94865837538462,85.60676810461538,86.26487783384616,86.92298756307693,87.5810972923077,88.23920702153846,88.89731675076924,{"y":89.55542648000001,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":70.841,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.355,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.85,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.423,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.977,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.459,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.162,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.665,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.162,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.067,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.767,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.774,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€116.25Average Price Target€105.92Lowest Price Target€89.56
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barrington Analyst forecast on DE:LHU
Michael Petusky
Barrington
Barrington
€103.33
Buy
9.35%
Upside
Reiterated
06/03/26
Analysts Offer Insights on Healthcare Companies: Ardent Health Partners, Inc. (NYSE: ARDT), Lemaitre Vascular (NASDAQ: LMAT) and Gilead Sciences (NASDAQ: GILD)
Stifel Nicolaus Analyst forecast on DE:LHU
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
€99.03→€103.33
Buy
9.35%
Upside
Reiterated
05/08/26
Lemaitre Vascular (LMAT) Gets a Buy from Stifel Nicolaus
Wells Fargo Analyst forecast on DE:LHU
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
€80.94→€89.56
Hold
-5.23%
Downside
Reiterated
05/06/26
Lemaitre Vascular (LMAT) Gets a Hold from Wells Fargo
Citizens JMP Analyst forecast on DE:LHU
Daniel Stauder
Citizens JMP
Citizens JMP
€101.61→€109.36
Buy
15.73%
Upside
Reiterated
05/06/26
LeMaitre price target raised to $127 from $118 at CitizensLeMaitre price target raised to $127 from $118 at Citizens
Sidoti Analyst forecast on DE:LHU
James Sidoti
Sidoti
Sidoti
€106.78→€113.67
Buy
20.28%
Upside
Reiterated
05/06/26
Lemaitre Vascular (LMAT) Receives a Buy from Sidoti
Lake Street Analyst forecast on DE:LHU
Frank Takkinen
Lake Street
Lake Street
€116.25
Buy
23.02%
Upside
Reiterated
05/06/26
LeMaitre price target raised to $135 from $110 at Lake StreetLeMaitre price target raised to $135 from $110 at Lake Street
KeyBanc Analyst forecast on DE:LHU
Brett Fishbin
KeyBanc
KeyBanc
―
Hold
―
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Lemaitre Vascular (NASDAQ: LMAT), Henry Schein (NASDAQ: HSIC) and Exelixis (NASDAQ: EXEL)
Roth MKM Analyst forecast on DE:LHU
Kyle Bauser
Roth MKM
Roth MKM
€93→€100.75
Buy
6.61%
Upside
Reiterated
02/26/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Teladoc (NYSE: TDOC), Alkermes (NASDAQ: ALKS) and Lemaitre Vascular (NASDAQ: LMAT)
Oppenheimer Analyst forecast on DE:LHU
Suraj Kalia
Oppenheimer
Oppenheimer
―
Hold
―
Reiterated
11/07/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Zymeworks (NASDAQ: ZYME), MBX Biosciences, Inc. (NASDAQ: MBX) and Lemaitre Vascular (NASDAQ: LMAT)
Cantor Fitzgerald Analyst forecast on DE:LHU
Ross Osborn
Cantor Fitzgerald
Cantor Fitzgerald
€81.81
Hold
-13.43%
Downside
Reiterated
08/11/25
Cantor Fitzgerald Sticks to Their Hold Rating for Lemaitre Vascular (LMAT)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barrington Analyst forecast on DE:LHU
Michael Petusky
Barrington
Barrington
€103.33
Buy
9.35%
Upside
Reiterated
06/03/26
Analysts Offer Insights on Healthcare Companies: Ardent Health Partners, Inc. (NYSE: ARDT), Lemaitre Vascular (NASDAQ: LMAT) and Gilead Sciences (NASDAQ: GILD)
Stifel Nicolaus Analyst forecast on DE:LHU
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
€99.03→€103.33
Buy
9.35%
Upside
Reiterated
05/08/26
Lemaitre Vascular (LMAT) Gets a Buy from Stifel Nicolaus
Wells Fargo Analyst forecast on DE:LHU
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
€80.94→€89.56
Hold
-5.23%
Downside
Reiterated
05/06/26
Lemaitre Vascular (LMAT) Gets a Hold from Wells Fargo
Citizens JMP Analyst forecast on DE:LHU
Daniel Stauder
Citizens JMP
Citizens JMP
€101.61→€109.36
Buy
15.73%
Upside
Reiterated
05/06/26
LeMaitre price target raised to $127 from $118 at CitizensLeMaitre price target raised to $127 from $118 at Citizens
Sidoti Analyst forecast on DE:LHU
James Sidoti
Sidoti
Sidoti
€106.78→€113.67
Buy
20.28%
Upside
Reiterated
05/06/26
Lemaitre Vascular (LMAT) Receives a Buy from Sidoti
Lake Street Analyst forecast on DE:LHU
Frank Takkinen
Lake Street
Lake Street
€116.25
Buy
23.02%
Upside
Reiterated
05/06/26
LeMaitre price target raised to $135 from $110 at Lake StreetLeMaitre price target raised to $135 from $110 at Lake Street
KeyBanc Analyst forecast on DE:LHU
Brett Fishbin
KeyBanc
KeyBanc
―
Hold
―
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Lemaitre Vascular (NASDAQ: LMAT), Henry Schein (NASDAQ: HSIC) and Exelixis (NASDAQ: EXEL)
Roth MKM Analyst forecast on DE:LHU
Kyle Bauser
Roth MKM
Roth MKM
€93→€100.75
Buy
6.61%
Upside
Reiterated
02/26/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Teladoc (NYSE: TDOC), Alkermes (NASDAQ: ALKS) and Lemaitre Vascular (NASDAQ: LMAT)
Oppenheimer Analyst forecast on DE:LHU
Suraj Kalia
Oppenheimer
Oppenheimer
―
Hold
―
Reiterated
11/07/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Zymeworks (NASDAQ: ZYME), MBX Biosciences, Inc. (NASDAQ: MBX) and Lemaitre Vascular (NASDAQ: LMAT)
Cantor Fitzgerald Analyst forecast on DE:LHU
Ross Osborn
Cantor Fitzgerald
Cantor Fitzgerald
€81.81
Hold
-13.43%
Downside
Reiterated
08/11/25
Cantor Fitzgerald Sticks to Their Hold Rating for Lemaitre Vascular (LMAT)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Lemaitre Vascular

3 Months
Daniel StauderCitizens JMP
Success Rate
7/10 ratings generated profit
70%
Average Return
+5.92%
Copying Daniel Stauder's trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +5.92% per trade.
1 Year
Michael PetuskyBarrington
Success Rate
22/36 ratings generated profit
61%
Average Return
+16.72%
Copying Michael Petusky's trades and holding each position for 1 Year would result in 61.11% of your transactions generating a profit, with an average return of +16.72% per trade.
2 Years
Daniel StauderCitizens JMP
Success Rate
8/10 ratings generated profit
80%
Average Return
+28.17%
Copying Daniel Stauder's trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +28.17% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LHU Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
7
7
7
5
6
Hold
3
2
2
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
9
9
7
8
In the current month, LHU has received 6 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. LHU average Analyst price target in the past 3 months is 105.92.
Each month's total comprises the sum of three months' worth of ratings.

LHU Financial Forecast

LHU Earnings Forecast

Next quarter’s earnings estimate for LHU is €0.70 with a range of €0.68 to €0.71. The previous quarter’s EPS was €0.59. LHU beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year LHU has Performed in-line its overall industry.
Next quarter’s earnings estimate for LHU is €0.70 with a range of €0.68 to €0.71. The previous quarter’s EPS was €0.59. LHU beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year LHU has Performed in-line its overall industry.

LHU Sales Forecast

Next quarter’s sales forecast for LHU is €61.57M with a range of €60.73M to €62.03M. The previous quarter’s sales results were €57.33M. LHU beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year LHU has Performed in-line its overall industry.
Next quarter’s sales forecast for LHU is €61.57M with a range of €60.73M to €62.03M. The previous quarter’s sales results were €57.33M. LHU beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year LHU has Performed in-line its overall industry.

LHU Stock Forecast FAQ

What is DE:LHU’s average 12-month price target, according to analysts?
Based on analyst ratings, Lemaitre Vascular’s 12-month average price target is 105.92.
    What is DE:LHU’s upside potential, based on the analysts’ average price target?
    Lemaitre Vascular has 12.08% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Lemaitre Vascular a Buy, Sell or Hold?
          Lemaitre Vascular has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Lemaitre Vascular’s share price target?
            The average share price target for Lemaitre Vascular is 105.92. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €116.25 ,and the lowest forecast is €89.56. The average share price target represents 12.08% Increase from the current price of €94.5.
              What do analysts say about Lemaitre Vascular?
              Lemaitre Vascular’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of Lemaitre Vascular?
                To buy shares of DE:LHU, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.